Roughly one in nine people on Earth do not have enough food to eat. And climate change is only making it harder for farmers to meet the global demand for food, according to the Intergovernmental Panel on Climate Change (IPCC). By 2030, the IPCC expects climate change to reduce crop and pasture yields by as much as 14 percent in some parts of the world. Adapting crops, livestock and fisheries will be critical for global food security.
UC San Diego Health and Tri-City Healthcare District announced today that they have entered into an exclusive, long-term strategic affiliation designed to enhance the delivery of high quality health care to patients in North San Diego County.
The most severe strep infections are often the work of one strain known as M1T1, named for the type of tentacle-like M protein projecting from the bacterium’s surface. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered a new way M1 contributes to strep virulence — the protein’s ability to hold off antimicrobial peptides. The study is published October 14 by Cell Host & Microbe.
A wireless charger that’s compatible with different consumer electronics from different brands is one step closer to becoming a reality thanks to research by electrical engineers at the University of California, San Diego. Researchers have developed a dual frequency wireless charging platform that could be used to charge multiple devices, such as smartphones, smartwatches, laptops and tablets, at the same time — regardless of which wireless standard, or frequency, each device supports.
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.
Many leukemias are caused by loss of the enzyme Pten. Some anti-leukemia treatments work by inhibiting another enzyme called Shp2. Researchers at University of California, San Diego School of Medicine have now found that mice lacking both of these enzymes can’t produce and sustain enough red blood cells. The study, published October 12 by PNAS, helps explain why anemia is a common side effect of anti-cancer drugs that target enzymes involved in tumor growth.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
